Department of Paediatric Respiratory and Sleep Medicine, Royal Brompton Hospital, London.
Department of Paediatric Respiratory and Sleep Medicine, Royal Hospital for Sick Children, Edinburgh; Department of Child Life and Health, University of Edinburgh.
Paediatr Respir Rev. 2017 Mar;22:52-59. doi: 10.1016/j.prrv.2016.08.002. Epub 2016 Aug 10.
Prader Willi syndrome, resulting from the partial deletion or lack of expression of a region of genes on the paternal chromosome 15, has a number of phenotypic features which predispose affected patients to ventilatory problems. These include generalised hypotonia, abnormal arousal and ventilatory responses to hypoxia and hypercapnia, scoliosis and frequently, obesity. The spectrum of the resulting respiratory complications thus runs from sleep disordered breathing, to aspiration and respiratory functional impairment. While the use of growth hormone, in conjunction with multidisciplinary clinical management, is currently the cornerstone of clinical care of these patients, concerns have been raised following reports of sudden death shortly after growth hormone initiation. This review summarizes the respiratory complications commonly seen and draws together the published literature on the impact of growth hormone in relation to various respiratory parameters, aiming to provide the reader with the necessary information to manage these patients as safely as possible.
普拉德-威利综合征是由于父源 15 号染色体上部分基因缺失或表达不足而导致的,其具有多种表型特征,使受影响的患者易发生通气问题。这些特征包括全身性低张力、觉醒异常以及对低氧和高碳酸血症的通气反应、脊柱侧凸,并且通常还伴有肥胖。因此,由此产生的呼吸并发症的范围从睡眠呼吸障碍到吸入和呼吸功能障碍。虽然生长激素的使用与多学科临床管理相结合,是目前这些患者临床护理的基石,但在生长激素治疗开始后不久就有突然死亡的报告后,人们对此表示担忧。这篇综述总结了常见的呼吸并发症,并汇集了关于生长激素对各种呼吸参数影响的文献,旨在为读者提供必要的信息,以尽可能安全地管理这些患者。